Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma

SIMPLE SUMMARY: The response rate to immune checkpoint inhibitor (ICI) monotherapy in hepatocellular carcinoma (HCC) is as low as 20%; therefore, it is important to identify the patient subgroups that respond to ICI. β-catenin activation is considered to be a key factor of ICI resistance. β-catenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Masahiro, Nishida, Naoshi, Aoki, Tomoko, Chishina, Hirokazu, Takita, Masahiro, Ida, Hiroshi, Hagiwara, Satoru, Minami, Yasunori, Ueshima, Kazuomi, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136695/
https://www.ncbi.nlm.nih.gov/pubmed/37190239
http://dx.doi.org/10.3390/cancers15082311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136695/
https://www.ncbi.nlm.nih.gov/pubmed/37190239
http://dx.doi.org/10.3390/cancers15082311

Ejemplares similares